QuidelOrtho Corporation QDEL Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$12.91 down $1.00, 7.19% at close Oct 16
Last close · Previous close $13.91
- Market cap
- $880.35MAt the Oct 16 close
- P/E ratio
- n/mLoss over last 12 months
- Diluted EPS
- −$15.39Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$12.91down $1.00, 7.19%Fri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$13.91Oct 15
- Volume1.79MOct 16 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume2.07MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $9.92 to $35.58; now $12.91
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 16 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
QDEL beat the S&P 500 in 1 of 7 periods.
| Period | QDEL and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | QDEL: up 19.9% S&P 500: up 1.5% | QDEL beat the S&P 500 by 18.4 percentage points Beat |
| 3M | QDEL: down 29.2% S&P 500: up 1.9% | QDEL trailed the S&P 500 by 31.1 percentage points Trailed |
| YTD | QDEL: down 54.8% S&P 500: up 12.8% | QDEL trailed the S&P 500 by 67.6 percentage points Trailed |
| 1Y | QDEL: down 54.6% S&P 500: up 16.8% | QDEL trailed the S&P 500 by 71.4 percentage points Trailed |
| Long term | ||
| 3Y | QDEL: down 81.0% S&P 500: up 81.5% −42.5% vs +22.0% a year | QDEL trailed the S&P 500 by 162.5 percentage points Trailed |
| 5Y | QDEL: down 89.9% S&P 500: up 83.1% −36.8% vs +12.9% a year | QDEL trailed the S&P 500 by 173.0 percentage points Trailed |
| 10Y | QDEL: down 38.0% S&P 500: up 319.6% −4.7% vs +15.4% a year | QDEL trailed the S&P 500 by 357.6 percentage points Trailed |
$10,000 invested in QDEL 10 years ago (Oct 14, 2016) would be worth about $6,201 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,964.
QDEL beat the S&P 500 in 1 of 7 periods.
| Period | QDEL and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | QDEL: up 19.9% S&P 500: up 1.2% | QDEL beat the S&P 500 by 18.7 percentage points Beat |
| 3M | QDEL: down 29.2% S&P 500: up 1.7% | QDEL trailed the S&P 500 by 30.9 percentage points Trailed |
| YTD | QDEL: down 54.8% S&P 500: up 11.9% | QDEL trailed the S&P 500 by 66.7 percentage points Trailed |
| 1Y | QDEL: down 54.6% S&P 500: up 15.5% | QDEL trailed the S&P 500 by 70.1 percentage points Trailed |
| Long term | ||
| 3Y | QDEL: down 81.0% S&P 500: up 75.0% −42.5% vs +20.5% a year | QDEL trailed the S&P 500 by 156.0 percentage points Trailed |
| 5Y | QDEL: down 89.9% S&P 500: up 71.2% −36.8% vs +11.4% a year | QDEL trailed the S&P 500 by 161.1 percentage points Trailed |
| 10Y | QDEL: down 38.0% S&P 500: up 258.1% −4.7% vs +13.6% a year | QDEL trailed the S&P 500 by 296.1 percentage points Trailed |
$10,000 invested in QDEL 10 years ago (Oct 14, 2016) would be worth about $6,201 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,813.
All-time high
$301.96
Closing high on . Now 95.7% below that record.
Split-adjusted daily closes since Mar 3, 1992.
Stock splits
QDEL hasn’t split since its price history begins in 1992.
Valuation
The Oct 16 close compared with the last 12 months of reported results (the four quarters to Jun 28, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
n/mDiluted EPS of −$15.39 over the last 12 months
A P/E ratio isn’t meaningful while earnings over the last 12 months are negative. When QDEL was profitable over the past five years, its P/E ranged from 2.9× to 381.7×, with a median of 7.3×. How to read P/E
Other valuation measures
- 0.3×Last 12 months’ revenue
Market value divided by revenue over the last 12 months. Useful when earnings are small or negative.
P/S = Market cap ÷ Revenue (last 12 months)Price-to-sales ratio - 0.5×Book value as of Jun 28, 2026
Price relative to accounting equity (book value) per share on the Jun 28, 2026 balance sheet. Asset-light companies often trade far above book value.
P/B = Price ÷ Book value per sharePrice-to-book ratio - −23.99%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $3.80BAt the Oct 16 close
What it would cost to buy the whole business: the market cap at the Oct 16 close, plus debt, minus cash and short-term investments from the Jun 28, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own QDEL DCF in Excel. Value QuidelOrtho with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 28, 2026. “Last 12 months” means the four quarters from Jun 30, 2025 to Jun 28, 2026, and balance-sheet figures are as of Jun 28, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $2.67Bdown 2.5%
- Net income
- −$1.05B
- Diluted EPS
- −$15.39
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 29, 2024) | $727.10M | −$19.90M | −$0.30 |
| Q4 FY24 (Dec 29, 2024) | $707.80M | −$178.40M | −$2.62 |
| Q1 FY25 (Mar 30, 2025) | $692.80M | −$12.70M | −$0.19 |
| Q2 FY25 (Jun 29, 2025) | $613.90M | −$255.40M | −$3.77 |
| Q3 FY25 (Sep 28, 2025) | $699.90M | −$733.00M | −$10.78 |
| Q4 FY25 (Dec 28, 2025) | $723.60M | −$130.70M | −$1.90 |
| Q1 FY26 (Mar 29, 2026) | $619.80M | −$91.80M | −$1.35 |
| Q2 FY26 (Jun 28, 2026) | $630.90M | −$92.90M | −$1.36 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $1.70B | $704.20M | $16.43 |
| FY22 (Jan 1, 2023) | $3.27B | $548.70M | $9.56 |
| FY23 (Dec 31, 2023) | $3.00B | −$10.10M | −$0.15 |
| FY24 (Dec 29, 2024) | $2.78B | −$2.05B | −$30.54 |
| FY25 (Dec 28, 2025) | $2.73B | −$1.13B | −$16.69 |
Margins
- Gross 44.6%
- Operating −30.8%
- Net −39.2%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- −$211.20MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow−$57.20MLast 12 months
- Capital spending$154.00MLast 12 months
- −7.9%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $5.20MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$0.00Last 12 months
Balance sheet
- $123.40MAs of Jun 28, 2026
Cash plus short- and long-term marketable securities on the Jun 28, 2026 balance sheet.
- Total debt$3.04BAs of Jun 28, 2026
- Net debt$2.92BAs of Jun 28, 2026
- 1.39As of Jun 28, 2026
Current assets divided by current liabilities on the Jun 28, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 1.71As of Jun 28, 2026
Total debt divided by shareholders’ equity on the Jun 28, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 3 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✗Net income was positive: not passed
- ✗Operating cash flow was positive: not passed
- ✗Return on assets improved: not passed
- ✓Operating cash flow exceeded net income: passed
- ✗Long-term debt fell relative to assets: not passed
- ✓Current ratio improved: passed
- ✗Share count didn’t rise: not passed
- ✗Gross margin improved: not passed
- ✓Asset turnover (revenue ÷ assets) improved: passed
- −55.3%Last 12 months
Over the last 12 months, QuidelOrtho lost money: its net loss was 55.3% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - −18.4%Last 12 months
Over the last 12 months, QuidelOrtho’s net loss was 18.4% of its total assets (averaged over the last four quarter-ends).
ROA = Net income (last 12 months) ÷ Average total assets
About QuidelOrtho Corporation
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- California, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
QDEL news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
QDEL stock FAQ
What is QDEL stock’s price today?
QuidelOrtho (QDEL) traded at $12.91 at the close on , down $1.00 (7.19%) from the previous close of $13.91. Over the past 52 weeks it has traded between $9.92 and $35.58.
If you invested $1,000 in QDEL 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in QDEL on would be worth about $620 at the close on , a total return of −38.0%. The same $1,000 would be worth $101 if invested five years ago, $454 if invested one year ago, $870 if invested 20 years ago, and $3,228 if invested 30 years ago. Past performance doesn’t predict future returns.
What is QuidelOrtho’s market cap?
QuidelOrtho’s market capitalization is about $880.3 million. That’s Tiingo’s daily market cap for , at that day’s closing price of $12.91 (how market cap works). QuidelOrtho reported 68.19M shares outstanding at the end of its latest quarter ().
What is QDEL’s P/E ratio?
QDEL’s P/E ratio isn’t meaningful right now because its earnings over the four quarters to are negative (diluted EPS of −$15.39). When it was profitable over the past five years, its P/E ranged from 2.9 to 381.7.
How much revenue does QuidelOrtho make?
QuidelOrtho reported $2.7 billion of revenue over the four quarters to , down 2.5% from the twelve months before. In its latest quarter (Q2 FY26, ended ) revenue was $630.9 million, up 2.8% from a year earlier.
Is QuidelOrtho profitable?
Not over the four quarters to . QuidelOrtho reported a net loss of $1.0 billion across those four quarters on $2.7 billion of revenue.
What are QDEL’s earnings per share?
QDEL’s diluted earnings per share were −$15.39 over the four quarters to , compared with −$6.88 in the twelve months before. The latest quarter (Q2 FY26) brought −$1.36 per share, against −$3.77 a year earlier (how EPS works).
Does QDEL pay a dividend?
QuidelOrtho hasn’t paid a dividend in the last twelve months.
What is QDEL’s 52-week high and low?
Over the past 52 weeks QDEL has traded as low as $9.92 and as high as $35.58. At $12.91 at the close on , it is 63.7% below that high and 30.1% above the low.
What is QDEL’s all-time high?
QDEL’s highest closing price was $301.96 on , adjusted for stock splits. At $12.91 at the close on , it is 95.7% below that record.
Has QDEL stock ever split?
No. QDEL hasn’t split since its price history begins in 1992.
How has QDEL stock performed?
Including dividends and measured to the close on , QDEL has returned −54.8% so far this year and −54.6% over the past year, and −89.9% over five years (−36.8% a year). Over the same periods the S&P 500, measured by SPY, returned +12.8%, +16.8% and +83.1%. Past performance doesn’t predict future returns.
What sector and industry is QuidelOrtho in?
QuidelOrtho is in the Healthcare sector and the Medical Devices industry, and is headquartered in California, USA.
What exchange does QDEL trade on?
QuidelOrtho trades on the Nasdaq under the ticker symbol QDEL. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.